CFG
IRWD icon

Citizens Financial Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Citizens Financial Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4,012
Closed -$44K – 681
2016
Q2 		$44K Hold
4,012
– – ﹤0.01% 374
2016
Q1 		$37K Buy
4,012
+2,006
+100% +$16.5K ﹤0.01% 389
2015
Q4 		$39K Buy
+2,006
New +$19.4K ﹤0.01% 384

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citizens Financial Group's IRWD Position: Q3 2016 in Review

Citizens Financial Group sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2016, closing a stake of 4,012 shares — an estimated $44K sold.

Citizens Financial Group first reported a position in IRWD in Q4 2015 and held it in 3 quarters. The position peaked at $44K in Q2 2016. 155 funds tracked by Wall St. Rank hold IRWD as of Q3 2016.

  • Citizens Financial Group reported no remaining Ironwood Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Citizens Financial Group sold 4,012 Ironwood Pharmaceuticals shares in Q3 2016, an estimated $44K.
  • Citizens Financial Group first reported a position in Ironwood Pharmaceuticals in Q4 2015 and held it in 3 quarters.
  • Citizens Financial Group's Ironwood Pharmaceuticals position peaked at $44K in Q2 2016.
  • 155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2016.

Based on Citizens Financial Group's 13F filing for Q3 2016, filed 10 Nov 2016.